Kura Oncology Inc
KURA
NASDAQ
Biotechnology
$10.86
USD
+0.77 (+7.63%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $915.26M
Volume 1.9M
Price Target
$24.00 – $38.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $38.00 and a min estimate of $24.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$31.00
+$6.3 vs prior
Implied Upside
+185.4%
+57.5% vs prior
Analyst Covering
2
-2 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
Low
Targets are widely dispersed - limited agreement on price
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Robert Driscoll | Wedbush | Buy | Maintained | 2 days ago | Plus | Plus | Plus |
Reni J. Benjamin | JMP Securities | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
GERN
Geron Corp
$1.47
▼ -4.2%
ARDX
Ardelyx Inc
$4.06
▲ +3.8%
DSGN
Design Therapeutics Inc
$14.83
▲ +3.1%
ODTX
Odyssey Therapeutics Inc
$20.73
▲ +0.1%
JANX
Janux Therapeutics Inc
$16.12
▲ +0.8%
SLDB
Solid Biosciences Inc
$9.20
▲ +1.3%
CADL
Candel Therapeutics Inc
$11.72
▼ -0.7%
OLMA
Olema Pharmaceuticals Inc
$10.63
▲ +1.1%
CLYM
Climb Bio Inc
$16.33
▲ +10.9%